Wende Hutton is a seasoned healthcare investor and is passionate about identifying, investing in and building companies that are revolutionizing the practice of medicine.
Over the last 15 years, Wende has facilitated the market entrance of over 11 novel and lifesaving medical devices, new drugs and diagnostics.
Wende began her venture career at Mayfield Fund in 1993, where she was a General Partner in the life sciences group until 2001.
During her tenure at Mayfield, Wende incubated Heartstream Inc. (HPQ) and Northstar Neuroscience Inc. (NSTR), working closely with those founding teams.
Most recently, she was a General Partner at Spring Ridge Ventures, a healthcare-focused seed fund.
Earlier in her career, Wende held senior operational management positions at GenPharm International and Nellcor in business development and marketing.
Wende sits on the boards of Altheos, Inc., Calibra Medical, ReVision Optics, Inc., Theraclone Sciences and Transcend Medical, Inc.
Wende holds a BA in human biology from Stanford University and an MBA from Harvard Business School, where she was a Baker Scholar.
She is an active member of several community service groups, including serving as task-force leader on obesity for the Santa Clara and Mid-Peninsula YMCAs.
Beyond her community service involvements, Wende’s first love is a field biology hike or lecture.
1993 - Jan, 2001
General Manager, Transgenic Lab Products
1991 - Jan, 1992
Director, International Business Unit; Dir of Business Development; Marketing
1986 - Jan, 1990